Article Versions Notes

Sharma VK, Misra B, McManus KT, Avula S, Nellaiappan K, Caskey M, Horowitz J, Nussenzweig MC, Seaman MS, Javeri I, et al. Characterization of Co-Formulated High-Concentration Broadly Neutralizing Anti-HIV-1 Monoclonal Antibodies for Subcutaneous Administration. Antibodies. 2020; 9(3):36. https://doi.org/10.3390/antib9030036

Sharma, Vaneet K., Bijay Misra, Kevin T. McManus, Sreenivas Avula, Kaliappanadar Nellaiappan, Marina Caskey, Jill Horowitz, Michel C. Nussenzweig, Michael S. Seaman, Indu Javeri, and et al. 2020. "Characterization of Co-Formulated High-Concentration Broadly Neutralizing Anti-HIV-1 Monoclonal Antibodies for Subcutaneous Administration" Antibodies 9, no. 3: 36. https://doi.org/10.3390/antib9030036

Sharma, V. K., Misra, B., McManus, K. T., Avula, S., Nellaiappan, K., Caskey, M., Horowitz, J., Nussenzweig, M. C., Seaman, M. S., Javeri, I., & Dey, A. K. (2020). Characterization of Co-Formulated High-Concentration Broadly Neutralizing Anti-HIV-1 Monoclonal Antibodies for Subcutaneous Administration. Antibodies, 9(3), 36. https://doi.org/10.3390/antib9030036